Publications and communications of Elodie GONNE

Lebeau, A., Kakkos, A., LEROI, N., Bours, V., Delbecque, K., Goffin, F., Gonne, E., & Gennigens, C. (05 December 2025). Targeting synthetic lethality: an effective therapeutic approach in ovarian and endometrial cancers. Therapeutic Advances in Medical Oncology, 17, 17588359251392106. doi:10.1177/17588359251392106

Darimont, C., Pauwen, S., Fiona, M., LEBEAU, A., Seidel, L., Gonne, E., Goffin, F., Kakkos, A., Gennigens, C., & Kridelka, F. (November 2025). RISK FACTORS OF RECURRENCE IN EARLY-STAGE VULVAR CANCER (FIGO2021 I-II): INSIGHTS FROM A RETROSPECTIVE STUDY. International Journal of Gynecological Cancer, 35 (11), 102538. doi:10.1016/j.ijgc.2025.102538

LEBEAU, A., Pauwen, S., Darimont, C., Fiona, M., Seidel, L., Gonne, E., Goffin, F., Kakkos, A., Kridelka, F., & Gennigens, C. (November 2025). RECURRENCE IN ADVANCED VULVAR CANCER (FIGO III-IVA): CHARACTERISTICS ANALYSIS OF LOCAL AND DISTANT RELAPSES. International Journal of Gynecological Cancer, 35 (11), 102533. doi:10.1016/j.ijgc.2025.102533

Meuris, F., Darimont, C., Pauwen, S., LEBEAU, A., Kakkos, A., Goffin, F., Kridelka, F., Gennigens, C., Gonne, E., & Seidel, L. (November 2025). IMPACT OF STROMAL INVASION DEPTH ON RECURRENCE RISK IN EARLY (FIGO I–II) AND ADVANCED (FIGO III–IVA) STAGES VULVAR CANCER. International Journal of Gynecological Cancer, 35 (11), 102539. doi:10.1016/j.ijgc.2025.102539

DHEUR, A., Kakkos, A., Danthine, D., Delbecque, K., Goffin, F., Gonne, E., Lovinfosse, P., Pleyers, C., THILLE, A., Kridelka, F., & Gennigens, C. (11 November 2024). Lymph node assessment in cervical cancer: current approaches. Frontiers in Oncology, 14. doi:10.3389/fonc.2024.1435532

Salmon, A.* , LEBEAU, A.* , Streel, S., Dheur, A., Schoenen, S., Goffin, F., Gonne, E., Kridelka, F., Kakkos, A.* , & Gennigens, C.*. (22 June 2024). Locally advanced and metastatic endometrial cancer: Current and emerging therapies. Cancer Treatment Reviews, 129, 102790. doi:10.1016/j.ctrv.2024.102790

Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866

Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203

Salmon, A., Dheur, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (October 2022). Endometrial cancer: lymphovascular space invasion is a negative prognostic factor [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.264

DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States.

Salmon, A., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (29 September 2022). Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis ? [Poster presentation]. IGCS 2022, New York, United States.

ONESTI, C. E., Schroeder, H., Rorive, A., Sautois, B., Lecocq, M., Goffin, M., Gonne, E., Collinge, A., Nicolaers, L., Wéra, O., Catot, A., Loly, C., Paulus, A., Sibille, A., Lousberg, L., Troisfontaine, F., Collignon, J., Gennigens, C., Frères, P., ... Jerusalem, G. (2021). Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study. Cancer Reports, 1571. doi:10.1002/cnr2.1571

LAPAILLE, L., DE CUYPERE, M., GOFFIN, F., KAKKOS, A., GONNE, E., HERMESSE, J., LOVINFOSSE, P., DELBECQUE, K., THILLE, A., Kridelka, F., & GENNIGENS, C. (2021). Cancer du col utérin localement avancé : approche multidisciplinaire. Revue Médicale de Liège, 76 (5-6), 507-514.

Jouret, G., GONNE, E., QUATRESOOZ, P., REGINSTER, M.-A., COLLINS, P., LEBAS, E., JERUSALEM, G., & NIKKELS, A. (2020). Cutaneous Breast Cancer Metastases Successfully Treated Using an Oxygen Flow Assisted Topical Administration of Methotrexate (OFAMTX). Dermatology and Therapy. doi:10.1007/s13555-020-00393-9

KAKKOS, A., GONNE, E., COIMBRA MARQUES, C., NERVO, P., REMACLE, G., THILLE, A., HAYETTE, M.-P., VAN LINTHOUT, C., KRIDELKA, F., & DELBECQUE, K. (2017). Le cas clinique du mois. Actinomycose pelvienne pseudo-tumorale : il fallait y penser. Revue Médicale de Liège, 72 (1), 10-13.

GONNE, E., COLLIGNON, J., JERUSALEM, G., & GENNIGENS, C. (2016). Le carcinome de site primitif inconnu, une entité pas si rare. Revue Médicale de Liège, 71 (10), 449-454.

COLIN, P.-E., SCHROEDER, H., GONNE, E., Hanocq, F., ANDRE, C., RORIVE, A., Jerusalem, G., & COLLIGNON, J. (2015). BIOPSIE DES LESIONS SUSPECTES CHEZ LES PATIENTS AYANT PRESENTE UN CANCER DU SEIN. Revue Médicale de Liège, 70 (11), 563-8.

FRERES, P., GONNE, E., COLLIGNON, J., GIOT, J.-B., GENNIGENS, C., & JERUSALEM, G. (2015). Prise en charge de la neutropénie fébrile chez le patient cancéreux. Revue Médicale de Liège, 70 (4), 195-200.

GONNE, E., Collignon, J., Kurth, W., Thiry, A., Henry, F., Jerusalem, G., & Gennigens, C. (2009). Angiosarcome sur lymphoedeme chronique: un cas de syndrome de Stewart-Treves. Revue Médicale de Liège, 64 (7-8), 409-13.